PanCryos
Dedicated to improving life quality for millions of people suffering from diabetes
Denmark
2 employees
Grant
Total: $71.43K
Biopharma, Biotechnology
General Information
Denmark
BounceWatch is an independent company data service, not affiliated with PanCryos. To contact PanCryos, visit pancryos.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does PanCryos compare?
A PDF of PanCryos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting PanCryos soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Denmark Market
Biopharma
About PanCryos
Business keywords: Stem cell therapy, Type 1 diabetes, Cell therapy, Pre-clinical development, Manufacturing scalability, Insulin cells, Allogeneic cell therapy, Novel IP, Safety, Large-scale manufacturing, Commercialization, Research and development, Diabetes treatment
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | €71.43K | 1 |
EASME - EU Executive Agency for SMEs
|
01 Aug 2018 |
PanCryos Alternatives & Competitors
View All Alternatives
Cell Therapy for All
Designing and delivering cell therapies to transform the lives of people with cancer.
The Better life with Anti-cancer immunotherapy
FAQ About PanCryos
Source: BounceWatch company record for PanCryos, https://bouncewatch.com/company/pancryos, updated 28 October 2024. When citing, please name BounceWatch and link this page.
